FV naltrexone of 50 mg No. 10 (VED) *
Producer: CJSC Moscow Pharmaceutical Factory Russia
Code of automatic telephone exchange: V03AB30
Release form: Firm dosage forms. Capsules.
General characteristics. Structure:
Active ingredient: each capsule soderdzhit 50 mg of Naltrexone of a hydrochloride.
Pharmacological properties:
FV naltrexone competitively contacts opioid receptors of all types and warns or eliminates effect of both endogenous opioids, and exogenous morfinopodobny medicines.
Indications to use:
- treatment of opioid drug addiction for the purpose of maintenance at a sick state at which opioids will not be able to have characteristic effect (as a part of complex therapy).
Drug is appointed only after stopping of an abstinence syndrome.
- treatment of an alcoholism.
Route of administration and doses:
Use of FV Naltrexone is possible in specialized narcological departments or is out-patient under observation of the doctor.
Side effects:
At use of FV Naltrexone according to indications in therapeutic doses at patients whose organism does not contain opioids development of serious side effects was not noted.
Contraindications:
- concomitant use of opioid analgetics;
- a positive take of the analysis of urine on availability of opioids;
- lack of data on conducting provocative test with Naloxonum;
- acute gastritis; - a liver failure;
- hypersensitivity to naltrexone.
Issue conditions:
According to the recipe
Packaging:
In packaging of 10 capsules.